U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


ORBIMED CAPITAL GP II LLC (0001281668)
State location: NY | State of Inc.: DE | Fiscal Year End: 1231
formerly: ORBIMED CAPITAL II LLC (until 2006-06-05)
Business Address
601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK NY 10022
(212) 739-6400
Mailing Address
601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK NY 10022
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
ACCELERON PHARMA INC 0001280600 2013-09-18 10 percent owner
SUPERNUS PHARMACEUTICALS INC
Current Name:SUPERNUS PHARMACEUTICALS, INC.
0001356576 2012-04-30 10 percent owner
INSULET CORP 0001145197 2007-05-14 director
Volcano CORP 0001354217 2006-06-14 director
GIVEN IMAGING LTD 0001126140 2006-05-24 director, 10 percent owner
CRYOCOR INC 0001125294 2005-07-13 10 percent owner
AVANIR PHARMACEUTICALS
Current Name:AVANIR PHARMACEUTICALS, INC.
0000858803 2004-09-14 director


Items 1 - 0

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016